SCHEMBL8868904

SCHEMBL8868904

COCSc1ccccc1N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ MAPT P10636 3/20 0.50
▸ POLB P06746 2/20 0.50
▸ APOBEC3G Q9HC16 2/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ HSD17B10 Q99714 3/20 0.47
▸ ALDH1A1 P00352 6/20 0.42
▸ SLC6A4 P31645 3/20 0.42
▸ SLC6A2 P23975 2/20 0.42
▸ SLC6A3 Q01959 2/20 0.42
▸ ADRA2B P18089 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ MAPK1 P28482 1/20 0.39
▸ LMNA P02545 3/20 0.38
▸ CYP3A4 P08684 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7620846 0.79 KMT2A (0.48) MEN1KMT2AMAPTPOLBAPOBEC3G
SCHEMBL8881481 0.78 MCHR1 (0.43) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL23734864 0.77 MTNR1A (0.50) MEN1KMT2AMAPTPOLBALDH1A1
SCHEMBL28867399 0.75 ALDH1A1 (0.33) MEN1KMT2APOLBAPOBEC3GHSD17B10
SCHEMBL10373330 0.75 MEN1 (0.39) MEN1KMT2AMAPTPOLBAPOBEC3G
SCHEMBL10373328 0.75 ALDH1A1 (0.41) MEN1KMT2AMAPTAPOBEC3GALDH1A1
SCHEMBL10374519 0.75 MEN1 (0.50) MEN1KMT2AMAPTAPOBEC3GALDH1A1
SCHEMBL29565819 0.75 MEN1 (0.58) MEN1KMT2AMAPTPOLBAPOBEC3G
SCHEMBL2857496 0.75 MEN1 (0.58) MEN1KMT2AMAPTPOLBAPOBEC3G
SCHEMBL11704851 0.74 MEN1 (0.62) MEN1KMT2AMAPTPOLBAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5624924-A Quinobenzothiazine antineoplastic agents ABBOTT LABORATORIES (US) 1997-04-29 — — US disclosed
EP-0608215-A1 QUINOBENZOXAZINE, QUINOBENZOTHIAZINE, AND PYRIDO-ACRIDINE ANTINEOPLASTIC AGENTS ABBOTT LABORATORIES (US) 1994-08-03 — — EP disclosed
US-5318965-A Administering to treat leukemia, melanoma, carcinoma of lung, colon, ovaries ABBOTT LABORATORIES (US) 1994-06-07 — — US disclosed
EP-0608215-A4 QUINOBENZOXAZINE, QUINOBENZOTHIAZINE, AND PYRIDO-ACRIDINE ANTINEOPLASTIC AGENTS. ABBOTT LAB (US) 1993-11-11 — — EP disclosed
WO-1993016702-A1 QUINOBENZOXAZINE, QUINOBENZOTHIAZINE, AND PYRIDO-ACRIDINE ANTINEOPLASTIC AGENTS ABBOTT LABORATORIES (US) 1993-09-02 — — WO disclosed
WO-1992003136-A1 QUINOBENZOXAZINE, QUINOBENZOTHIAZINE, AND PYRIDO-ACRIDINE ANTINEOPLASTIC AGENTS ABBOTT LABORATORIES (US) 1992-03-05 — — WO disclosed
EP-0162333-B1 QUINO-BENZOTHIAZINE ANTIBACTERIAL COMPOUNDS ABBOTT LABORATORIES (US) 1990-06-27 — — EP disclosed
EP-0162333-A1 Quino-benzothiazine antibacterial compounds ABBOTT LABORATORIES (US) 1985-11-27 — — EP disclosed
US-4533663-A Quino-benzothiazine antibacterial compounds ABBOTT LABORATORIES (US) 1985-08-06 — — US disclosed
US-4529725-A 1-Pyridine substituted quino-benzothiazine ABBOTT LABORATORIES (US) 1985-07-16 — — US disclosed
US-4528285-A Methylenedioxy quino-benzothiazine derivatives ABBOTT LABORATORIES (US) 1985-07-09 — — US disclosed
Send feedback